Api A M, Belsito D, Botelho D, Bruze M, Burton G A, Buschmann J, Cancellieri M A, Dagli M L, Date M, Dekant W, Deodhar C, Fryer A D, Jones L, Joshi K, Kumar M, Lapczynski A, Lavelle M, Lee I, Liebler D C, Moustakas H, Na M, Penning T M, Ritacco G, Romine J, Sadekar N, Schultz T W, Selechnik D, Siddiqi F, Sipes I G, Sullivan G, Thakkar Y, Tokura Y
Research Institute for Fragrance Materials, Inc., 50 Tice Boulevard, Woodcliff Lake, NJ, 07677, USA.
Member Expert Panel, Columbia University Medical Center, Department of Dermatology, 161 Fort Washington Ave., New York, NY, 10032, USA.
Food Chem Toxicol. 2022 Mar;161 Suppl 1:112853. doi: 10.1016/j.fct.2022.112853. Epub 2022 Feb 9.
The existing information supports the use of this material as described in this safety assessment. 5-Hydroxy-7-decenoic acid δ-lactone was evaluated for genotoxicity, repeated dose toxicity, reproductive toxicity, local respiratory toxicity, phototoxicity/photoallergenicity, skin sensitization, and environmental safety. Data from read-across material tetrahydro-6-(3-pentenyl)-2H-pyran-2-one (CAS # 32764-98-0) show that 5-hydroxy-7-decenoic acid δ-lactone is not expected to be genotoxic. The repeated dose, reproductive, and local respiratory toxicity endpoints were evaluated using the Threshold of Toxicological Concern (TTC) for a Cramer Class I material, and the exposure to 5-hydroxy-7-decenoic acid δ-lactone is below the TTC (0.03 mg/kg/day, 0.03 mg/kg/day, and 1.4 mg/day, respectively). Data show that there are no safety concerns for 5-hydroxy-7-decenoic acid δ-lactone for skin sensitization under the current declared levels of use. The phototoxicity/photoallergenicity endpoints were evaluated based on ultraviolet/visible (UV/Vis) spectra; 5-hydroxy-7-decenoic acid δ-lactone is not expected to be phototoxic/photoallergenic. The environmental endpoints were evaluated; 5-Hydroxy-7-decenoic acid δ-lactone was found not to be Persistent, Bioaccumulative, and Toxic (PBT) as per the International Fragrance Association (IFRA) Environmental Standards, and its risk quotients, based on its current volume of use in Europe and North America (i.e., Predicted Environmental Concentration/Predicted No Effect Concentration [PEC/PNEC]), are <1.
现有信息支持将本材料用于本安全评估中所述用途。对5-羟基-7-癸烯酸δ-内酯进行了遗传毒性、重复剂量毒性、生殖毒性、局部呼吸道毒性、光毒性/光致敏性、皮肤致敏性及环境安全性评估。来自交叉参照物质四氢-6-(3-戊烯基)-2H-吡喃-2-酮(CAS编号:32764-98-0)的数据表明,预计5-羟基-7-癸烯酸δ-内酯无遗传毒性。使用Cramer I类物质的毒理学关注阈值(TTC)对重复剂量、生殖及局部呼吸道毒性终点进行了评估,5-羟基-7-癸烯酸δ-内酯的暴露量低于TTC(分别为0.03 mg/kg/天、0.03 mg/kg/天和1.4 mg/天)。数据表明,在当前宣称的使用水平下,5-羟基-7-癸烯酸δ-内酯不存在皮肤致敏的安全问题。基于紫外/可见(UV/Vis)光谱对光毒性/光致敏性终点进行了评估;预计5-羟基-7-癸烯酸δ-内酯无光毒性/光致敏性。对环境终点进行了评估;根据国际香精协会(IFRA)环境标准,发现5-羟基-7-癸烯酸δ-内酯不属于持久性、生物累积性和毒性(PBT)物质,基于其目前在欧洲和北美的使用量计算的风险商数(即预测环境浓度/预测无效应浓度[PEC/PNEC])<1。